Inpatient management of migraine (Q38363902)

2 September 2017

1 reference

title

Inpatient management of migraine (English)

1 reference

2 September 2017

1 reference

Michael J Marmura

1

1 reference

PubMed ID

25704007

2 September 2017

Stephanie Wrobel Goldberg

series ordinal

2

1 reference

2 September 2017

1 April 2015

1 reference

Current Neurology and Neuroscience Reports

2 September 2017

1 reference

2 September 2017

15

1 reference

2 September 2017

13

1 reference

2 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-015-0539-z

2 September 2017

0 references

cites work

Global Burden of Disease 2005: call for collaborators

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Costs associated with outpatient, emergency room and inpatient care for migraine in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Comprehensive inpatient treatment for intractable migraine: a prospective long-term outcome study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Chronic care costs in managed care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Excessive opioid use and the development of chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Efficacy of multidisciplinary treatment in a tertiary referral headache centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Preventive pharmacotherapy in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

21 January 2018

Integrated headache care

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Inpatient treatment of headache: an evidence-based assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

A comparative study of selected patient variables as risk factors in hospitalization for chronic headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Comprehensive inpatient treatment of refractory chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Inpatient treatment of headache: long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Intravenous dihydroergotamine for inpatient management of refractory primary headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Aspirin is efficacious for the treatment of acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Intravenous valproate sodium in the treatment of daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Treatment of primary headache disorders with intravenous valproate: initial outpatient experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Intravenous lidocaine in the treatment of refractory headache: a retrospective case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Mexiletine for refractory chronic daily headache: a report of nine cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Intravenous propofol: unique effectiveness in treating intractable migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Sedative dosing of propofol for treatment of migraine headache in the emergency department: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Improvement of refractory migraine headache by propofol: case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Intravenous propofol in the treatment of refractory headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Headache and acute illness in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Acute headache in children and adolescents presenting to the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Inpatient treatment of status migraine with dihydroergotamine in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Tolerability and effectiveness of prochlorperazine for intractable migraine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Intravenous dihydroergotamine therapy for pediatric abdominal migraines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

The effectiveness of hospitalization in the treatment of paediatric idiopathic headache patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Effectiveness of a 3-week multimodal inpatient pain treatment for adolescents suffering from chronic pain: statistical and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

The idiopathic intracranial hypertension treatment trial: clinical profile at baseline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for headache chronification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Obesity and migraine: the effect of age, gender and adipose tissue distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Improvement of migraine headaches in severely obese patients after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Are There Predictive Factors for Long-Term Outcome after Withdrawal in Drug-Induced Chronic Daily Headache?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

The Link Between Pain Patient and Analgesic Medication is Greater in Migraine than in Rheumatic Disease Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0539-Z

Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE

21 January 2018

1 reference

12 December 2020

Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs

1 reference

12 December 2020

Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department

1 reference

12 December 2020

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Standards of care for treating headache in primary care practice. National Headache Foundation.

1 reference

12 December 2020

Repetitive intravenous dihydroergotamine as therapy for intractable migraine.

1 reference

12 December 2020

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors

1 reference

12 December 2020

From the Centers for Disease Control. Prevalence of chronic migraine headaches--United States, 1980-1989

1 reference

12 December 2020

Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study

1 reference

12 December 2020

A double blind study of metoclopramide in the treatment of migraine attacks

1 reference

12 December 2020

Spectrum and frequency of pediatric illness presenting to a general community hospital emergency department

1 reference

12 December 2020

Migraine and reduced work performance: a population-based diary study

1 reference

12 December 2020

Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache

1 reference

12 December 2020

The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials

1 reference

12 December 2020

Droperidol treatment of status migrainosus and refractory migraine

1 reference

12 December 2020

Burden of migraine in the United States: disability and economic costs.

1 reference

12 December 2020

Intravenous magnesium for acute benign headache in the emergency department: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

The hospital management of severe migrainous headache

1 reference

12 December 2020

Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches

1 reference

12 December 2020

Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMA

1 reference

12 December 2020

Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings

1 reference

12 December 2020

Treatment of migraine attacks with an analgesic combination (Mersyndol).

1 reference

12 December 2020

In-patient treatment of chronic daily headache using dihydroergotamine: a long-term follow-up study

1 reference

12 December 2020

Outcome of medication overuse headache after abrupt in-patient withdrawal

1 reference

12 December 2020

Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review

1 reference

12 December 2020

10.1007/S11910-015-0539-Z

Identifiers

DOI

1 reference

PubMed ID

25704007

Dimensions Publication ID

2 September 2017

0 references

1 reference

PubMed ID

25704007